Searched for
FIDAXOMICIN
For moderate risk takers: 5 midcap stocks from different sectors with potential upside of up to 36%Unlike last quarter of 2023, when nifty and sensex used to witness correction and mid-cap index was able move higher. Since the start of 20...- Top five stocks that can return 10-40% in a yearSome macroeconomic signals like CAD are likely to fall on increase in exports and fall in gold imports, which should support the bullish se...
- Top five mid-cap stocks that reported better than expected Q2 results“In all, 105 mid-cap companies that have reported results have seen their net profits advance by 8 per cent, only half that of the broader ...
- Top five mid-cap stocks that reported better than expected Q2 resultsIndia Inc. might be showing signs of slowdown, however, a large number of companies are beating analysts' estimates this earnings season.
- Biocon's drug development partner Optimer receives US patent for FidaxomicinThe closest competitor for Fidaxomicin is vancomycin - an antibiotec injectable manufactured and supplied by Strides Arcolabs.
- Stocks to watch: Godrej Consumer, Tata Chemicals, Aban Offshore, Mahindra Satyam, Lupin, Biocon, Tata PowerThe Godrej Group has consolidated the operations of insecticides joint venture Godrej Sara Lee with Godrej Consumer Products in a bid to ta...
Load More